These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 11460576)

  • 21. Metformin, a promising oral antihyperglycemic for the treatment of noninsulin-dependent diabetes mellitus.
    Wildasin EM; Skaar DJ; Kirchain WR; Hulse M
    Pharmacotherapy; 1997; 17(1):62-73. PubMed ID: 9017766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Promising new approaches.
    Reasner CA
    Diabetes Obes Metab; 1999 May; 1 Suppl 1():S41-8. PubMed ID: 11220287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Combination treatment with insulin and metformin in type 2 diabetes. Improves glycemic control and prevents weight gain].
    Hermann LS; Melander A
    Lakartidningen; 1999 Dec; 96(50):5616-9. PubMed ID: 10643226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Value of biguanide in therapy of diabetes mellitus].
    Haupt E; Panten U
    Med Klin (Munich); 1997 Aug; 92(8):472-9, 505. PubMed ID: 9340472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between metformin and abdominal aortic aneurysm.
    Raffort J; Hassen-Khodja R; Jean-Baptiste E; Lareyre F
    J Vasc Surg; 2020 Mar; 71(3):1056-1062. PubMed ID: 31727461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Encouraging Metformin data reported by researchers.
    Ghazourian N
    Posit Living; 2000 Dec; 9(10):15. PubMed ID: 12154754
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of metformin on insulin resistance in heart failure. Which came first: the chicken or the egg?
    Lexis CP; van der Horst IC; Lipsic E
    Eur J Heart Fail; 2012 Nov; 14(11):1197-8. PubMed ID: 23054099
    [No Abstract]   [Full Text] [Related]  

  • 28. Metformin in equine metabolic syndrome: an enigma or a dead duck?
    Durham AE
    Vet J; 2012 Jan; 191(1):17-8. PubMed ID: 21885304
    [No Abstract]   [Full Text] [Related]  

  • 29. Research progress of metformin in the treatment of liver fibrosis.
    Zhang A; Qian F; Li Y; Li B; Yang F; Hu C; Sun W; Huang Y
    Int Immunopharmacol; 2023 Mar; 116():109738. PubMed ID: 36696857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequency of inappropriate metformin prescriptions.
    Horlen C; Malone R; Bryant B; Dennis B; Carey T; Pignone M; Rothman R
    JAMA; 2002 May; 287(19):2504-5. PubMed ID: 12020329
    [No Abstract]   [Full Text] [Related]  

  • 31. Metformin inhibits IL-1β secretion via impairment of NLRP3 inflammasome in keratinocytes: implications for preventing the development of psoriasis.
    Tsuji G; Hashimoto-Hachiya A; Yen VH; Takemura M; Yumine A; Furue K; Furue M; Nakahara T
    Cell Death Discov; 2020; 6():11. PubMed ID: 32194991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized Placebo Control Study of Metformin in Psoriasis Patients with Metabolic Syndrome (Systemic Treatment Cohort).
    Singh S; Bhansali A
    Indian J Endocrinol Metab; 2017; 21(4):581-587. PubMed ID: 28670544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacotherapy in the Management of Pediatric Obesity.
    Kelly AS; Fox CK
    Curr Diab Rep; 2017 Aug; 17(8):55. PubMed ID: 28646356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized placebo control study of insulin sensitizers (Metformin and Pioglitazone) in psoriasis patients with metabolic syndrome (Topical Treatment Cohort).
    Singh S; Bhansali A
    BMC Dermatol; 2016 Aug; 16(1):12. PubMed ID: 27531132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AMPK activation: a therapeutic target for type 2 diabetes?
    Coughlan KA; Valentine RJ; Ruderman NB; Saha AK
    Diabetes Metab Syndr Obes; 2014; 7():241-53. PubMed ID: 25018645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of dietary nonstructural carbohydrate content on activation of 5'-adenosine monophosphate-activated protein kinase in liver, skeletal muscle, and digital laminae of lean and obese ponies.
    Burns TA; Watts MR; Weber PS; McCutcheon LJ; Geor RJ; Belknap JK
    J Vet Intern Med; 2014; 28(4):1280-8. PubMed ID: 24750267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An evolving scientific basis for the prevention and treatment of pediatric obesity.
    Katzmarzyk PT; Barlow S; Bouchard C; Catalano PM; Hsia DS; Inge TH; Lovelady C; Raynor H; Redman LM; Staiano AE; Spruijt-Metz D; Symonds ME; Vickers M; Wilfley D; Yanovski JA
    Int J Obes (Lond); 2014 Jul; 38(7):887-905. PubMed ID: 24662696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-diabetic effects of CTB-APSL fusion protein in type 2 diabetic mice.
    Liu Y; Gao Z; Guo Q; Wang T; Lu C; Chen Y; Sheng Q; Chen J; Nie Z; Zhang Y; Wu W; Lv Z; Shu J
    Mar Drugs; 2014 Mar; 12(3):1512-29. PubMed ID: 24633252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patterns of use of insulin-sensitizing agents among diabetic, borderline diabetic and non-diabetic women in the National Health and Nutrition Examination Surveys.
    Beydoun H; Kancherla V; Stadtmauer L; Beydoun M
    Gynecol Endocrinol; 2013 Apr; 29(4):350-6. PubMed ID: 23323803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacotherapy for childhood obesity: present and future prospects.
    Sherafat-Kazemzadeh R; Yanovski SZ; Yanovski JA
    Int J Obes (Lond); 2013 Jan; 37(1):1-15. PubMed ID: 22929210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.